Global and Japan Next Generation Antibody Therapeutics Market Size, Status and Forecast 2020-2026

Global and Japan Next Generation Antibody Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Antibody Drug Conjugates (ADCs)
1.2.3 Bispecific Antibodies (BsAbs)
1.2.4 Fc Engineered Antibodies
1.2.5 Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
1.2.6 Biosimilar Antibody (Ab) Products
1.3 Market by Application
1.3.1 Global Next Generation Antibody Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Antibody Therapeutics Market Perspective (2015-2026)
2.2 Global Next Generation Antibody Therapeutics Growth Trends by Regions
2.2.1 Next Generation Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Next Generation Antibody Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Next Generation Antibody Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Antibody Therapeutics Players by Market Size
3.1.1 Global Top Next Generation Antibody Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Next Generation Antibody Therapeutics Revenue
3.4 Global Next Generation Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Antibody Therapeutics Revenue in 2019
3.5 Key Players Next Generation Antibody Therapeutics Area Served
3.6 Key Players Next Generation Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Next Generation Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Antibody Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2021-2026)
5 Next Generation Antibody Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Next Generation Antibody Therapeutics Market Size (2015-2026)
6.2 North America Next Generation Antibody Therapeutics Market Size by Type (2015-2020)
6.3 North America Next Generation Antibody Therapeutics Market Size by Application (2015-2020)
6.4 North America Next Generation Antibody Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Next Generation Antibody Therapeutics Market Size (2015-2026)
7.2 Europe Next Generation Antibody Therapeutics Market Size by Type (2015-2020)
7.3 Europe Next Generation Antibody Therapeutics Market Size by Application (2015-2020)
7.4 Europe Next Generation Antibody Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Next Generation Antibody Therapeutics Market Size (2015-2026)
8.2 China Next Generation Antibody Therapeutics Market Size by Type (2015-2020)
8.3 China Next Generation Antibody Therapeutics Market Size by Application (2015-2020)
8.4 China Next Generation Antibody Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Next Generation Antibody Therapeutics Market Size (2015-2026)
9.2 Japan Next Generation Antibody Therapeutics Market Size by Type (2015-2020)
9.3 Japan Next Generation Antibody Therapeutics Market Size by Application (2015-2020)
9.4 Japan Next Generation Antibody Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Next Generation Antibody Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Next Generation Antibody Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Next Generation Antibody Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Next Generation Antibody Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Next Generation Antibody Therapeutics Introduction
11.1.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Next Generation Antibody Therapeutics Introduction
11.2.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.2.5 Roche Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Next Generation Antibody Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Next Generation Antibody Therapeutics Introduction
11.4.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.4.5 Amgen Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Next Generation Antibody Therapeutics Introduction
11.5.4 AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.5.5 AstraZeneca Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Next Generation Antibody Therapeutics Introduction
11.6.4 Bayer Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.6.5 Bayer Recent Development
11.7 Takeda Pharmaceuticals
11.7.1 Takeda Pharmaceuticals Company Details
11.7.2 Takeda Pharmaceuticals Business Overview
11.7.3 Takeda Pharmaceuticals Next Generation Antibody Therapeutics Introduction
11.7.4 Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.7.5 Takeda Pharmaceuticals Recent Development
11.8 Biogen
11.8.1 Biogen Company Details
11.8.2 Biogen Business Overview
11.8.3 Biogen Next Generation Antibody Therapeutics Introduction
11.8.4 Biogen Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.8.5 Biogen Recent Development
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Next Generation Antibody Therapeutics Introduction
11.9.4 Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.9.5 Seattle Genetics Recent Development
11.10 ImmunoGen
11.10.1 ImmunoGen Company Details
11.10.2 ImmunoGen Business Overview
11.10.3 ImmunoGen Next Generation Antibody Therapeutics Introduction
11.10.4 ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
11.10.5 ImmunoGen Recent Development
11.11 Kyowa Hakko Kirin
10.11.1 Kyowa Hakko Kirin Company Details
10.11.2 Kyowa Hakko Kirin Business Overview
10.11.3 Kyowa Hakko Kirin Next Generation Antibody Therapeutics Introduction
10.11.4 Kyowa Hakko Kirin Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
10.11.5 Kyowa Hakko Kirin Recent Development
11.12 Xencor
10.12.1 Xencor Company Details
10.12.2 Xencor Business Overview
10.12.3 Xencor Next Generation Antibody Therapeutics Introduction
10.12.4 Xencor Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
10.12.5 Xencor Recent Development
11.13 Dyax Corp
10.13.1 Dyax Corp Company Details
10.13.2 Dyax Corp Business Overview
10.13.3 Dyax Corp Next Generation Antibody Therapeutics Introduction
10.13.4 Dyax Corp Revenue in Next Generation Antibody Therapeutics Business (2015-2020)
10.13.5 Dyax Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Antibody Drug Conjugates (ADCs)
Table 4. Key Players of Bispecific Antibodies (BsAbs)
Table 5. Key Players of Fc Engineered Antibodies
Table 6. Key Players of Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Table 7. Key Players of Biosimilar Antibody (Ab) Products
Table 8. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Next Generation Antibody Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Next Generation Antibody Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Next Generation Antibody Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Next Generation Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Next Generation Antibody Therapeutics Market Share by Regions (2021-2026)
Table 14. Next Generation Antibody Therapeutics Market Market Trends
Table 15. Next Generation Antibody Therapeutics Market Drivers
Table 16. Next Generation Antibody Therapeutics Market Challenges
Table 17. Next Generation Antibody Therapeutics Market Restraints
Table 18. Global Next Generation Antibody Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Next Generation Antibody Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Antibody Therapeutics as of 2019)
Table 21. Global Next Generation Antibody Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Next Generation Antibody Therapeutics Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Next Generation Antibody Therapeutics Market Size Share by Type (2015-2020)
Table 27. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2021-2026)
Table 28. Global Next Generation Antibody Therapeutics Market Size Share by Application (2015-2020)
Table 29. Global Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Next Generation Antibody Therapeutics Market Size Share by Application (2021-2026)
Table 31. North America Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Next Generation Antibody Therapeutics Market Share by Type (2015-2020)
Table 33. North America Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Next Generation Antibody Therapeutics Market Share by Application (2015-2020)
Table 35. North America Next Generation Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Next Generation Antibody Therapeutics Market Share by Country (2015-2020)
Table 37. Europe Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Next Generation Antibody Therapeutics Market Share by Type (2015-2020)
Table 39. Europe Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Next Generation Antibody Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Next Generation Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Next Generation Antibody Therapeutics Market Share by Country (2015-2020)
Table 43. China Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 44. China Next Generation Antibody Therapeutics Market Share by Type (2015-2020)
Table 45. China Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 46. China Next Generation Antibody Therapeutics Market Share by Application (2015-2020)
Table 47. China Next Generation Antibody Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 48. China Next Generation Antibody Therapeutics Market Share by Region (2015-2020)
Table 49. Japan Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Next Generation Antibody Therapeutics Market Share by Type (2015-2020)
Table 51. Japan Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Next Generation Antibody Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Next Generation Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Next Generation Antibody Therapeutics Market Share by Country (2015-2020)
Table 55. Southeast Asia Next Generation Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Next Generation Antibody Therapeutics Market Share by Type (2015-2020)
Table 57. Southeast Asia Next Generation Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Next Generation Antibody Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Next Generation Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Next Generation Antibody Therapeutics Market Share by Country (2015-2020)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Product
Table 64. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Product
Table 69. Roche Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 70. Roche Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Product
Table 74. Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Product
Table 79. Amgen Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 80. Amgen Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Product
Table 84. AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 90. Bayer Recent Development
Table 91. Takeda Pharmaceuticals Company Details
Table 92. Takeda Pharmaceuticals Business Overview
Table 93. Takeda Pharmaceuticals Product
Table 94. Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 95. Takeda Pharmaceuticals Recent Development
Table 96. Biogen Business Overview
Table 97. Biogen Product
Table 98. Biogen Company Details
Table 99. Biogen Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 100. Biogen Recent Development
Table 101. Seattle Genetics Company Details
Table 102. Seattle Genetics Business Overview
Table 103. Seattle Genetics Product
Table 104. Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 105. Seattle Genetics Recent Development
Table 106. ImmunoGen Company Details
Table 107. ImmunoGen Business Overview
Table 108. ImmunoGen Product
Table 109. ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 110. ImmunoGen Recent Development
Table 111. Kyowa Hakko Kirin Company Details
Table 112. Kyowa Hakko Kirin Business Overview
Table 113. Kyowa Hakko Kirin Product
Table 114. Kyowa Hakko Kirin Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 115. Kyowa Hakko Kirin Recent Development
Table 116. Xencor Company Details
Table 117. Xencor Business Overview
Table 118. Xencor Product
Table 119. Xencor Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 120. Xencor Recent Development
Table 121. Dyax Corp Company Details
Table 122. Dyax Corp Business Overview
Table 123. Dyax Corp Product
Table 124. Dyax Corp Revenue in Next Generation Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 125. Dyax Corp Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Antibody Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antibody Drug Conjugates (ADCs) Features
Figure 3. Bispecific Antibodies (BsAbs) Features
Figure 4. Fc Engineered Antibodies Features
Figure 5. Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Features
Figure 6. Biosimilar Antibody (Ab) Products Features
Figure 7. Global Next Generation Antibody Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Next Generation Antibody Therapeutics Report Years Considered
Figure 12. Global Next Generation Antibody Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Next Generation Antibody Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Next Generation Antibody Therapeutics Market Share by Regions (2021-2026)
Figure 15. Global Next Generation Antibody Therapeutics Market Share by Players in 2019
Figure 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Antibody Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2019
Figure 18. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 46. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 48. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 49. AstraZeneca Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 50. Bayer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 51. Takeda Pharmaceuticals Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 52. Biogen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 53. Seattle Genetics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 54. ImmunoGen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 55. Kyowa Hakko Kirin Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 56. Xencor Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 57. Dyax Corp Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs